iDexis fights back against SAHPRA over GLP-1 recall

Stephen Grootes speaks to iDexis Managing Director Ruaan Louw, about the company's response to SAHPRA's instruction to recall its compounded semaglutide and tirzepatide products. iDexis disputes the regulator's findings, insisting its compounding processes comply with legal and pharmaceutical standards, that its ingredients are sourced from internationally approved manufacturers, and that more than 214,000 patients have used its products without reported adverse events. The Money Show is a podcast hosted by well-known journalist and radio presenter, Stephen Grootes. He explores the latest economic trends, business developments, investment opportunities, and personal finance strategies. Each episode features engaging conversations with top newsmakers, industry experts, financial advisors, entrepreneurs, and politicians, offering you thought-provoking insights to navigate the ever-changing financial landscape. Thank you for listening to a podcast from The Money Show Listen live Primedia+ weekdays from 18:00 and 20:00 (SA Time) to The Money Show with Stephen Grootes broadcast on 702 and CapeTalk For more from the show, go to or find all the catch-up podcasts here

You can listen to iDexis fights back against SAHPRA over GLP-1 recall online on Radio and Podcast. Open the player on this page to stream the available audio.

iDexis fights back against SAHPRA over GLP-1 recall is an episode from The Best of the Money Show by Primedia Broadcasting.

This episode is 9:57 long.

This episode was published on Jun 3, 2026.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from The Best of the Money Show when more episodes are available from the podcast feed.